scholarly journals A Phase II Multicenter Study of Visilizumab, Humanized Anti-CD3 Antibody, to Treat Steroid-Refractory Acute Graft-versus-Host Disease

2005 ◽  
Vol 11 (6) ◽  
pp. 465-471 ◽  
Author(s):  
Paul A. Carpenter ◽  
James Lowder ◽  
Laura Johnston ◽  
Haydar Frangoul ◽  
Hanna Khoury ◽  
...  
Keyword(s):  
Phase Ii ◽  
Graft Versus Host Disease ◽  
Multicenter Study ◽  
Host Disease ◽  
Graft Versus Host ◽  
Steroid Refractory ◽  
Acute Graft

scholarly journals Alemtuzumab as Treatment of Steroid-Refractory Acute Graft-versus-Host Disease: Results of a Phase II Study

2009 ◽  
Vol 15 (5) ◽  
pp. 639-642 ◽  
Author(s):  
Carmen Martínez ◽  
Carlos Solano ◽  
Christelle Ferrá ◽  
Antonia Sampol ◽  
David Valcárcel ◽  
...  
Keyword(s):  
Phase Ii ◽  
Graft Versus Host Disease ◽  
Phase Ii Study ◽  
Host Disease ◽  
Graft Versus Host ◽  
Steroid Refractory ◽  
Acute Graft
Sign in / Sign up

Export Citation Format

Share Document